Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Emtricitabine (FTC) Treatment Report
What is Emtricitabine (FTC)?

Emtricitabine is a nucleoside reverse transcriptase inhibitors (NRTI) used with other medications to treat HIV infection in patients with or without AIDS. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat my HIV 9 1
General health 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 100%
Mild
0 0%
None
0 0%

Most commonly reported side effects

Diarrhea
1 100%
Stomach cramps
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  1 mg daily 200 daily 200 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7  

Stop Reasons

Why Patients Stopped Taking Emtricitabine (FTC) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
1 100% Side effects too severe: 100%

See all 1 patient who’ve stopped taking Emtricitabine (FTC)

Currently Taking Emtricitabine (FTC)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
2

Stopped Taking Emtricitabine (FTC)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 100%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

Report created on November 22, 2009.